270 related articles for article (PubMed ID: 21490132)
21. A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells.
Shen W; Chen C; Guan Y; Song X; Jin Y; Wang J; Hu Y; Xin T; Jiang Q; Zhong L
Int J Biol Macromol; 2017 Nov; 104(Pt A):681-686. PubMed ID: 28634059
[TBL] [Abstract][Full Text] [Related]
22. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
Hahm ER; Singh SV
Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
[TBL] [Abstract][Full Text] [Related]
23. Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.
Rajendran P; Li F; Shanmugam MK; Kannaiyan R; Goh JN; Wong KF; Wang W; Khin E; Tergaonkar V; Kumar AP; Luk JM; Sethi G
Cancer Prev Res (Phila); 2012 Apr; 5(4):631-43. PubMed ID: 22369852
[TBL] [Abstract][Full Text] [Related]
24. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
[TBL] [Abstract][Full Text] [Related]
25. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
[TBL] [Abstract][Full Text] [Related]
26. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
[TBL] [Abstract][Full Text] [Related]
27. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
[TBL] [Abstract][Full Text] [Related]
28. LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.
Liu A; Liu Y; Li PK; Li C; Lin J
Anticancer Res; 2011 Jun; 31(6):2029-35. PubMed ID: 21737619
[TBL] [Abstract][Full Text] [Related]
29. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.
Li F; Fernandez PP; Rajendran P; Hui KM; Sethi G
Cancer Lett; 2010 Jun; 292(2):197-207. PubMed ID: 20053498
[TBL] [Abstract][Full Text] [Related]
30. Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
Morisaki T; Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M
Anticancer Res; 2013 Apr; 33(4):1387-95. PubMed ID: 23564777
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma.
Liu T; Ma H; Shi W; Duan J; Wang Y; Zhang C; Li C; Lin J; Li S; Lv J; Lin L
Int J Oncol; 2017 Aug; 51(2):555-562. PubMed ID: 28714512
[TBL] [Abstract][Full Text] [Related]
32. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C
Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899
[TBL] [Abstract][Full Text] [Related]
33. COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.
Cervello M; Bachvarov D; Cusimano A; Sardina F; Azzolina A; Lampiasi N; Giannitrapani L; McCubrey JA; Montalto G
OMICS; 2011 Jun; 15(6):383-92. PubMed ID: 21410330
[TBL] [Abstract][Full Text] [Related]
34. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
Behari J; Zeng G; Otruba W; Thompson MD; Muller P; Micsenyi A; Sekhon SS; Leoni L; Monga SP
J Hepatol; 2007 May; 46(5):849-57. PubMed ID: 17275129
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
Jiang Y; Chen P; Hu K; Dai G; Li J; Zheng D; Yuan H; He L; Xie P; Tu M; Peng S; Qu C; Lin W; Chung RT; Hong J
J Cell Mol Med; 2021 Feb; 25(3):1568-1582. PubMed ID: 33410581
[TBL] [Abstract][Full Text] [Related]
37. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
[TBL] [Abstract][Full Text] [Related]
38. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
Li SJ; Sui MH; Sun ZX; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
[TBL] [Abstract][Full Text] [Related]
39. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
Roy KR; Reddy GV; Maitreyi L; Agarwal S; Achari C; Vali S; Reddanna P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):903-11. PubMed ID: 19685055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
